APA (7th ed.) Citation

Dratch, L., Kinnamon, D. D., Harrington, E. A., Goldman, J., Fong, J. C., Jones, T., . . . Roggenbuck, J. (2024). Response to "assessment of risk of ALS conferred by the GGGGCC hexanucleotide expansion in C9orf72 among first-degree relatives of patients with ALS carrying the repeat expansion". Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 25(7/8), 797. https://doi.org/10.1080/21678421.2024.2362854

Chicago Style (17th ed.) Citation

Dratch, Laynie, Daniel D. Kinnamon, Elizabeth A. Harrington, Jill Goldman, Jamie C. Fong, Tara Jones, Wendy R. Uhlmann, and Jennifer Roggenbuck. "Response to "Assessment of Risk of ALS Conferred by the GGGGCC Hexanucleotide Expansion in C9orf72 Among First-degree Relatives of Patients with ALS Carrying the Repeat Expansion"." Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration 25, no. 7/8 (2024): 797. https://doi.org/10.1080/21678421.2024.2362854.

MLA (9th ed.) Citation

Dratch, Laynie, et al. "Response to "Assessment of Risk of ALS Conferred by the GGGGCC Hexanucleotide Expansion in C9orf72 Among First-degree Relatives of Patients with ALS Carrying the Repeat Expansion"." Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, vol. 25, no. 7/8, 2024, p. 797, https://doi.org/10.1080/21678421.2024.2362854.